{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:06:50Z","timestamp":1784945210251,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.yrtph.2003.07.004","type":"journal-article","created":{"date-parts":[[2003,10,11]],"date-time":"2003-10-11T09:41:53Z","timestamp":1065865313000},"page":"345-367","source":"Crossref","is-referenced-by-count":43,"title":["Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling"],"prefix":"10.1016","volume":"38","author":[{"given":"C.R","family":"Kirman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E","family":"Meek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L","family":"Gargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2003.07.004_BIB1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0041-008X(87)90281-X","article-title":"Physiologically based pharmacokinetics and the risk assessment process for methylene chloride","volume":"87","author":"Andersen","year":"1987","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0041-008X(91)90264-F","article-title":"Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans","volume":"108","author":"Andersen","year":"1991","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/20018091094303","article-title":"Uncertainty\/safety factors in health risk assessment: opportunities for improvement","volume":"7","author":"Beck","year":"2001","journal-title":"Hum. Ecol. Risk Assess."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1006\/taap.1994.1068","article-title":"Computer simulation of the lactational transfer of tetrachloroethylene in rats using a physiologically based model","volume":"125","author":"Byczkowski","year":"1994","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1289\/ehp.0211085","article-title":"A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment","volume":"110","author":"Clewell III","year":"2002","journal-title":"Environ. Health Perspect."},{"issue":"Suppl. 2","key":"10.1016\/j.yrtph.2003.07.004_BIB6","first-page":"283","article-title":"Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment","volume":"108","author":"Clewell III","year":"2001","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/0041-008X(90)90324-N","article-title":"Development of a physiologically based pharmacokinetic model for chloroform","volume":"103","author":"Corley","year":"1990","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/taap.2000.8918","article-title":"A physiological toxicokinetic model for exogenous and endogenous ethylene and ethylene oxide in rat, mouse, and human: formation of 2-hydroxyethyl adducts with hemoglobin and DNA","volume":"165","author":"Csanady","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF03035414","article-title":"A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man","volume":"68","author":"Csanady","year":"1994","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB10","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/jps.2600751106","article-title":"Interspecies scaling of regional drug delivery","volume":"75","author":"Dedrick","year":"1986","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/jama.1992.03480010091030","article-title":"Effects of ranitidine on blood alcohol levels afer ethanol ingestion. Comparison with other H2-receptor antagonists","volume":"267","author":"DiPadova","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.yrtph.2003.07.004_BIB12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0041-008X(90)90249-T","article-title":"Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate","volume":"106","author":"Gearhart","year":"1990","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0378-4274(93)90126-I","article-title":"Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE)","volume":"68","author":"Gearhart","year":"1993","journal-title":"Toxicol. Lett."},{"issue":"Suppl 11","key":"10.1016\/j.yrtph.2003.07.004_BIB14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1289\/ehp.94102s1151","article-title":"Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters","volume":"102","author":"Gearhart","year":"1994","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB15","unstructured":"IPCS., 1994. Assessing human health risks of chemicals: derivation of guidance values for health-based exposure limits, Environmental Health Criteria No. 170"},{"key":"10.1016\/j.yrtph.2003.07.004_BIB16","doi-asserted-by":"crossref","unstructured":"Krishnan, K., Andersen, M.E., 1991. In: Rescigno, A., Thakur, A.K. (Eds.), Interspecies Scaling in Pharmacokinetics. New Trends in Pharmacokinetics. Plenum Press, NY","DOI":"10.1007\/978-1-4684-8053-5_12"},{"key":"10.1016\/j.yrtph.2003.07.004_BIB17","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3109\/00498259009046839","article-title":"Interspecies scaling and comparisons in drug development and toxicokinetics","volume":"20","author":"Ings","year":"1990","journal-title":"Xenobiotica"},{"key":"10.1016\/j.yrtph.2003.07.004_BIB18","first-page":"1202","article-title":"Applications and limitations of interspecies scaling and in vitro extrapolation in pharmacokinetics","volume":"26","author":"Lin","year":"1998","journal-title":"Drug Metab. Disposition"},{"key":"10.1016\/j.yrtph.2003.07.004_BIB19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0169-2607(97)00020-5","article-title":"A computer model and program for xenobiotic disposition during pregnancy","volume":"53","author":"Luecke","year":"1997","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB20","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/jps.2600640926","article-title":"Fluorocarbon aerosol propellants VI: interspecies differences in solubilities in blood and plasma and their possible implications in toxicity studies","volume":"64","author":"Niazi","year":"1975","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.yrtph.2003.07.004_BIB21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1539-6924.1989.tb01269.x","article-title":"Interspecies conversion of kinetically equivalent doses","volume":"9","author":"O\u2019Flaherty","year":"1989","journal-title":"Risk Anal."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/oxfordjournals.alcalc.a008163","article-title":"Development and application of a physiologically based pharmacokinetic model for ethanol in the mouse","volume":"31","author":"Pastino","year":"1996","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.yrtph.2003.07.004_BIB23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/taap.1997.8161","article-title":"A comparison of physiologically based pharmacokinetic model predictions and experimental data for inhaled ethanol in male and female B6C3F1 mice, F344 rats, and humans","volume":"145","author":"Pastino","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/toxsci\/55.2.256","article-title":"Application of a physiologically based pharmacokinetic model to estimate the bioavailability of ethanol in male rats: distinction between gastric and hepatic pathways of metabolic clearance","volume":"55","author":"Pastino","year":"2000","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1081\/DCT-100100110","article-title":"Genetic polymorphisms in ethanol metabolism: issues and goals for physiologically based pharmacokinetic modeling","volume":"23","author":"Pastino","year":"2000","journal-title":"Drug Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2003.07.004_BIB26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0041-008X(84)90064-4","article-title":"A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans","volume":"73","author":"Ramsey","year":"1984","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/taap.1996.0036","article-title":"In vivo and in vitro studies of perchloroethylene metabolism for physiologically based pharmacokinetic modeling in rats, mice, and humans","volume":"136","author":"Reitz","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/taap.1996.0079","article-title":"Predicting cancer risk from vinyl chloride exposure with a physiologically based pharmacokinetic model","volume":"137","author":"Reitz","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB29","unstructured":"Reitz, R.H., Hays, S.M., Gargas, M.L., 1997. Addressing priority data needs for methylene chloride with physiologically based pharmacokinetic modeling. Prepared for the Agency for Toxic Substances and Disease Registry on behalf of the Halogenated Solvents Industry Alliance by RHR Consulting Services and McLaren\/Hart. February 4, 1997"},{"key":"10.1016\/j.yrtph.2003.07.004_BIB30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0041-008X(90)90148-N","article-title":"Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling","volume":"105","author":"Reitz","year":"1990","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.yrtph.2003.07.004_BIB31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/02652039309374152","article-title":"Data-derived safety factors for the evaluation of food additives and environmental contaminants","volume":"0","author":"Renwick","year":"1993","journal-title":"Food Addit. Contam."},{"issue":"6","key":"10.1016\/j.yrtph.2003.07.004_BIB32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1539-6924.1998.tb01117.x","article-title":"Empirical scaling of single oral lethal doses across mammalian species based on a large database","volume":"18","author":"Rhomberg","year":"1998","journal-title":"Risk Anal."},{"issue":"1","key":"10.1016\/j.yrtph.2003.07.004_BIB33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/toxsci\/62.1.124","article-title":"Proposed occupational exposure limits for select ethylene glycol ethers using PBPK models and Monte Carlo simulations","volume":"62","author":"Sweeney","year":"2001","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.yrtph.2003.07.004_BIB34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/toxsci\/71.1.27","article-title":"Physiologically based pharmacokinetic model parameter estimation and sensitivity and variability analyses for acrylonitrile disposition in humans","volume":"71","author":"Sweeney","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/00984100050082085","article-title":"Comparative metabolism of carbon tetrachloride in rats, mice, and hamsters using gas uptake and PBPK modeling","volume":"60","author":"Thrall","year":"2000","journal-title":"J. Toxicol. Environ. Health A"},{"key":"10.1016\/j.yrtph.2003.07.004_BIB36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1539-6924.1990.tb01052.x","article-title":"Tissue dosimetry for reactive metabolites","volume":"10","author":"Travis","year":"1990","journal-title":"Risk Anal."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB37","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0041-008X(90)90037-U","article-title":"Pharmacokinetics of benzene","volume":"102","author":"Travis","year":"1990","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2003.07.004_BIB38","unstructured":"U.S. EPA., 1986. Guidelines for carcinogen risk assessment. Federal Register 51(185), 33992\u201334003"},{"key":"10.1016\/j.yrtph.2003.07.004_BIB39","unstructured":"U.S. EPA. (1992). Draft report: A Cross-Species Scaling Factor for Carcinogen Risk Assessment Based on Equivalence of mg\/kg3\/4\/day. Federal Register 57(109), 24152\u201324173. 28"},{"key":"10.1016\/j.yrtph.2003.07.004_BIB40","unstructured":"U.S. EPA., 1999. Proposed Guidelines for Carcinogen Risk Assessment. EPA-600-P92-003C. Washington, DC: U.S. Environmental Protection Agency, Office of Research and Development"},{"key":"10.1016\/j.yrtph.2003.07.004_BIB41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/152873901750128344","article-title":"Analysis of methylmercury disposition in humans utilizing a PBPK model and animal pharmacokinetic data","volume":"63","author":"Young","year":"2001","journal-title":"J. Toxicol. Environ. Health A"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230003001016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230003001016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T01:25:28Z","timestamp":1585185928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230003001016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0273230003001016"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2003.07.004","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}